Level Four Advisory Services’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-457
| Closed | -$30K | – | 687 |
|
|
2021
Q1 | $30K | Hold |
457
| – | – | ﹤0.01% | 627 |
|
|
2020
Q4 | $16K | Hold |
457
| – | – | ﹤0.01% | 589 |
|
|
2020
Q3 | $25K | Sell |
457
-307
| -40% | -$16.8K | ﹤0.01% | 537 |
|
|
2020
Q2 | $29K | Hold |
764
| – | – | ﹤0.01% | 562 |
|
|
2020
Q1 | $19K | Hold |
764
| – | – | ﹤0.01% | 484 |
|
|
2019
Q4 | $37K | Hold |
764
| – | – | ﹤0.01% | 559 |
|
|
2019
Q3 | $38K | Sell |
764
-143
| -16% | -$7.11K | ﹤0.01% | 501 |
|
|
2019
Q2 | $83K | Sell |
907
-3
| -0.3% | -$275 | 0.01% | 516 |
|
|
2019
Q1 | $134K | Sell |
910
-36
| -4% | -$5.3K | 0.01% | 496 |
|
|
2018
Q4 | $149K | Hold |
946
| – | – | 0.02% | 501 |
|
|
2018
Q3 | $232K | Buy |
946
+39
| +4% | +$9.56K | 0.03% | 523 |
|
|
2018
Q2 | $203K | Buy |
+907
| New | +$203K | 0.01% | 579 |
|